Jennifer Anne Williams Net Worth

The estimated Net Worth of Jennifer Anne Williams is at least 8.07 百万$ dollars as of 24 August 2018. Jennifer Williams owns over 1,064 units of GenMark Diagnostics Inc stock worth over 4,648,519$ and over the last 14 years Jennifer sold GNMK stock worth over 3,419,873$.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Jennifer Williams GNMK stock SEC Form 4 insiders trading

Jennifer has made over 80 trades of the GenMark Diagnostics Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently Jennifer sold 1,064 units of GNMK stock worth 7,618$ on 24 August 2018.

The largest trade Jennifer's ever made was selling 38,681 units of GenMark Diagnostics Inc stock on 15 September 2017 worth over 351,223$. On average, Jennifer trades about 4,192 units every 29 days since 2010. As of 24 August 2018 Jennifer still owns at least 193,366 units of GenMark Diagnostics Inc stock.

You can see the complete history of Jennifer Williams stock trades at the bottom of the page.

Insiders trading at GenMark Diagnostics Inc

Over the last 14 years, insiders at GenMark Diagnostics Inc have traded over 27,572,889$ worth of GenMark Diagnostics Inc stock and bought 454,838 units worth 2,182,328$ . The most active insiders traders include Hany Massarany、Jon Faiz Kayyem、Kevin C Oboyle. On average, GenMark Diagnostics Inc executives and independent directors trade stock every 5 days with the average trade being worth of 141,403$. The most recent stock trade was executed by Michael Gleeson on 14 April 2021, trading 27,667 units of GNMK stock currently worth 326,471$.

What does GenMark Diagnostics Inc do?

Complete history of Jennifer Williams stock trades at GenMark Diagnostics Inc

GenMark Diagnostics Inc executives and stock owners

GenMark Diagnostics Inc executives and other stock owners filed with the SEC include:

• Scott Mendel,
  President, Chief Executive Officer, Director
• Johnny Ek,
  Chief Financial Officer
• Michael Gleeson,
  Senior Vice President, Corporate Accounts
• Eric Stier,
  Senior Vice President, General Counsel, Secretary
• James Fox,
  Non-Executive Independent Director
• Kevin O'Boyle,
  Independent Chairman of the Board
• Lisa Giles,
  Independent Director
• Daryl Faulkner,
  Independent Director
• Michael Kagnoff,
  Independent Director
• Tyler Jensen,
  Senior Vice President - Engineering and Product Technical Support
• Jon Faiz Kayyem,
  President & CEO
• Jennifer Anne Williams,
  SVP Global Operations
• Wade R. Stevenson,
  SVP, North America Sales
• Brian Andrew Mitchell,
  SVP, Operations
• Christine Shaw,
  VP, Assay Development
• John Frederick Ek,
  Chief Financial Officer
• Richard B Slansky,
  Chief Financial Officer
• Stephen T Worland,
  Director
• Jeffrey Alan Hawkins,
  SVP, Marketing & Bus Dev
• Ingo Chakravarty,
  SVP, International
• Christopher M Gleeson,
  Director
• James B. Mc Nally,
  SVP, Marketing and Bus. Dev.
• Jorge Garces,
  SVP, Research & Development
• Paul Ross,
  CFO & Secretary
• Pankaj Singhal,
  Sr. VP, Product Dev & Mftg
• Matthew Robert Cohen,
  SVP, Gen Counsel & Secretary
• John Bellano,
  SR. VP, Commercial Operations
• Steven J Kemper,
  CFO, Treasurer & Secretary
• Bradley Calvin,
  Senior VP, Global Marketing
• Scott Alexander O'brien,
  SVP, Global Mktg & Int'l Sales
• Hany Massarany,
  President and CEO
• Sarah Hollis Winkler,
  VP, Human Resources
• Alan Baer Maderazo,
  VP, Qual, Reg, & Clin Affairs
• Michael John Harkins,
  SVP, Sales
• Abdul Chohan,
  SVP Operations